Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
Reactivation of human cytomegalovirus in immunosuppressed transplant patients can cause severe complications. Here, Krishnaet al. show that a fusion toxin protein that specifically binds the viral surface protein US28 can be used to kill latently infected monocytes and their progenitor cells in vitr...
Guardado en:
Autores principales: | B. A. Krishna, K. Spiess, E. L. Poole, B. Lau, S. Voigt, T. N. Kledal, M. M. Rosenkilde, J. H. Sinclair |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b51dc5db95748729925ab3ac515e35e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies
por: Timo W. M. De Groof, et al.
Publicado: (2021) -
Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection
por: Benjamin A. Krishna, et al.
Publicado: (2017) -
Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency
por: Elizabeth G. Elder, et al.
Publicado: (2019) -
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.
por: Frederic Vigant, et al.
Publicado: (2013) -
A Single-Cell Approach to the Elusive Latent Human Cytomegalovirus Transcriptome
por: Felicia Goodrum, et al.
Publicado: (2018)